Biocon Ltd. — Capital/Financing Update 2019

Jun 17, 2019

==> picture [146 x 38] intentionally omitted <==

June 17, 2019
ToTheSecretaryBSELimitedDepartmentofCorporateServicesPhiroze Jeejeebhoy Towers,DalalStreet, Mumbai-400001	ToTheSecretaryNationalStockExchangeofIndia LimitedCorporate CommunicationDepartmentExchangePlaza,SandraKurlaComplexMumbai-400 050
Scrip Code- 532523	ScripSymbol-BlOCON

Sl.No.	Particulars	Information
1.	Amount and percentageoftheturnoverorrevenueorincomeandnetworthcontributed by suchunit/divisionofthe listedentityduringthe last financialyear	Inter-segment revenue from the said undertakingduringFY2018-19 was approximatelyINR489 Croreswhichis17%ofrevenue from operationsoftheCompanyforFY19.
2.	Date on whichthe agreementforApproval by Board of Directorsofthe Company onsalehasbeen enteredintoIJune 17,2019.
3.	Expected dateofcompletionofsale/disposal	July 1, 2019 orasmutually agreed.
4.	Consideration receivedfromsuchsale/disposal	INR45 Crores (Rupees FortyFiveCrores)
5.	BriefdetailsofbuyersandBBIL,a wholly owned subsidiary.whether anyofthebuyers belongtothepromoter/promotergroupMs. Kiran Mazumdar Shaw, Chairperson and Managingcompanies. If yes, detailsthereof;Directorofthe Company and oneoftheprorrlQj:ersofItheCompany isa DirectorinBBIL./oNL~

		Mr.RussellWalls,Independent Director andDr.Arun SChandavarkar,CEO&Joint Managing DirectoroftheCompany are Directorson the BoardofBBIL.
6.	Whetheritisa related partytransaction,ifyes,whetheritisat'arm's length'	Yes,witha whollyowned subsidiary and at book value.
7.	Areaofbusinessofentities	Bioconisengaged in thebusinessofdevelopment,manufacture andsaleofsmallmolecules and noveldrugs besides distributionofBranded formulations(consisting primarilyofBiosimilars).BBILisengaged in the businessofmanufactureofBiosimilars (including BrandedFormulations).
8.	Rationale for slumpsaleIThe transferofBFI businessonslump salebasiswill leadito consolidation of , arketingand manufacturing1activities relatingtoBFIbusiness under a single entityJwith common leadership and achieve synergies_I_valueaccretion for thegroup.

==> picture [43 x 32] intentionally omitted <==